The Canadian Institutes of Health Research launched a new COVID-19 funding opportunity for operating grants called the “COVID-19 Clinical Epidemiology Research Rapid Response.” The application deadline is this Friday, March 27, and successful applicants will be notified of the decision on April 1. The competition description emphasizes the viruses “many unknown epidemiological parameters, particularly with respect…
Topic: Health Tech
Accel-RX co-founder Natalie Dakers comes full circle with adMare BioInnovations
Now joined with Admare BioInnovations, the Vancouver-based business accelerator Accel-Rx will be able to offer better opportunities to grow for early-stage health sciences companies.
Why does innovation stop at the boardroom door?
The established pathways for commercialization are changing. New market forces require innovators and customers to improve their collaborations and adopt a more holistic systems perspective.
Reports: Q1 2018 records strong VC interest, but PE growth ‘slow’
Investments in innovative companies were up in the first quarter of 2018 (Q1/18) across several sectors with venture capital funds leading the way, according to two new reports on Canadian activity. However, when it comes to private equity investments, one report indicates that investments were relatively slow but still bigger in value.
CDRD, MNI and Merck join forces to develop new therapeutics
Two research institutes and a multinational pharmaceutical firm are partnering to launch NeuroCDRD, a novel drug development platform that aims to accelerate the development of therapeutics for debilitating neurological diseases such as Parkinson’s disease and amyotrophic lateral sclerosis. The Centre for Drug Research and Development (CDRD) will contribute its translational expertise while the Montreal Neurological…